Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.045 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |